Technical Analysis for AVDL - Avadel Pharmaceuticals plc

Grade Last Price % Change Price Change
D 8.62 0.82% 0.07
AVDL closed up 0.82 percent on Friday, April 16, 2021, on 31 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down
Historical AVDL trend table...

Date Alert Name Type % Chg
Bollinger Band Squeeze Range Contraction 0.00%
20 DMA Resistance Bearish 0.82%
Fell Below 50 DMA Bearish 0.82%
Bollinger Band Squeeze Range Contraction 0.82%
20 DMA Resistance Bearish -1.82%
Crossed Above 50 DMA Bullish -1.82%
Pocket Pivot Bullish Swing Setup -1.82%
Bollinger Band Squeeze Range Contraction -1.82%
MACD Bearish Centerline Cross Bearish 0.94%
Pocket Pivot Bullish Swing Setup 0.94%
Older End-of-Day Signals for AVDL ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Trending on StockTwits about 7 hours ago
50 DMA Resistance about 24 hours ago
10 DMA Resistance about 24 hours ago
60 Minute Opening Range Breakout 1 day ago
Rose Above 10 DMA 1 day ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Avadel Pharmaceuticals plc Description

Avadel Pharmaceuticals plc operates as a specialty pharmaceutical company in the United States, France, and Ireland. The company primarily develops FT218, which is in a Phase 3 clinical trial for the treatment of narcolepsy patients suffering from excessive daytime sleepiness (EDS) and cataplexy. It also markets three sterile injectable drugs used in the hospital setting, including Akovaz that is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia; Bloxiverz, a cholinesterase inhibitor indicated for the reversal of the effects of non-depolarizing neuromuscular blocking agents after surgery; and Vazculep, a phenylephrine hydrochloride injection indicated for the treatment of clinically important hypotension. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals PLC in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin, Ireland.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Pharmaceutical Drugs Organ Systems Surgery Chloride Psychoactive Drugs Amines Anesthesia Reversal Sleep Disorders Choline Narcolepsy Phenols Cataplexy Cholinesterase Muscle Relaxants Phenylephrine

Is AVDL a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 13.49
52 Week Low 4.83
Average Volume 502,722
200-Day Moving Average 7.27
50-Day Moving Average 8.73
20-Day Moving Average 8.78
10-Day Moving Average 8.67
Average True Range 0.46
ADX 8.08
+DI 20.95
-DI 21.39
Chandelier Exit (Long, 3 ATRs ) 8.41
Chandelier Exit (Short, 3 ATRs ) 9.59
Upper Bollinger Band 9.22
Lower Bollinger Band 8.35
Percent B (%b) 0.31
BandWidth 9.93
MACD Line -0.02
MACD Signal Line 0.03
MACD Histogram -0.0534
Fundamentals Value
Market Cap 502.31 Million
Num Shares 58.3 Million
EPS 0.32
Price-to-Earnings (P/E) Ratio 26.60
Price-to-Sales 10.29
Price-to-Book 2.38
PEG Ratio 0.07
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 9.01
Resistance 3 (R3) 9.00 8.86 8.94
Resistance 2 (R2) 8.86 8.76 8.86 8.92
Resistance 1 (R1) 8.74 8.70 8.80 8.75 8.90
Pivot Point 8.60 8.60 8.63 8.61 8.60
Support 1 (S1) 8.48 8.50 8.54 8.49 8.34
Support 2 (S2) 8.34 8.44 8.35 8.32
Support 3 (S3) 8.22 8.34 8.30
Support 4 (S4) 8.23